From: Predictor of cognitive impairment: metabolic syndrome or circadian syndrome
Measure | Categorical cut point | Included in MetS | Included in CircS |
---|---|---|---|
Elevated waist circumference | Population- and country- specific definitions (≥ 85 cm in men, ≥ 80 cm in women) | √ | √ |
Elevated triglycerides (drug treatment for elevated triglycerides is an alternate indicator) | ≥ 150 mg dL− 1 (1.7 mmol L− 1) | √ | √ |
Reduced HDL-C (drug treatment for reduced HDL-C is an alternate indicator) | < 40 mg dL− 1 (1.0 mmol L− 1) in men; < 50 mg dL− 1 (1.3 mmol L− 1) in women; | √ | √ |
Elevated blood pressure (antihypertensive drug treatment in a patient with a history of hypertension is an alternate indicator) | Systolic ≥ 130 and/or diastolic ≥ 85 mmHg | √ | √ |
Elevated fasting glucose (drug treatment of elevated glucose is an alternate indicator) | ≥ 100 mg dL− 1 | √ | √ |
Short sleep | < 6 h day− 1 |  | √ |
Depression symptom | 10 item CES-D score ≥ 10 |  | √ |
Definition criteria |  | ≥ 3 components | ≥ 4 components |